Pharmacokinetics of repinotan in healthy and brain injured animals
โ Scribed by Thomas Schwarz; Bernhard Beckermann; Klaus Buehner; Frank Mauler; Joachim Schuhmacher; Dietrich Seidel; Wolfram Steinke; Corinna Weinz; Dieter Zimmerd
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 223 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.458
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The pharmacokinetics and tolerability of intravenous (IV) rizatriptan (MK-0462), a novel 5-HT 1D/1B receptor agonist for the acute oral treatment of migraine, were examined in an open, singledose, four-period, randomized crossover study in healthy females. Results of this study indicated that IV riz
## Abstract A traumatically brain injured (TBI) adolescent exhibited physical aggression requiring physical intervention. Aggressive behavior was eliminated in 2 weeks when a point system with response cost and contingent home visits were used. The point system alone maintained aggression at zero e
A study was conducted to assess the safety, tolerability, and pharmacokinetics of single intravenous (IV) doses of 5-90pgkg-' of MK-462, and the effect of food on the pharmacokinetics of MK-462 administered orally to healthy males. Results of this study indicate that IV doses of MK-462 from 5 to 90p
Objectives: To determine the effect of reduced hepatic function on the pharmacokinetics of minoxidil. The pharmacokinetics of antipyrine, lorazepam, and indocyanine green were included as indicators of hepatic function. Methods: Eight mild cirrhotics and eight healthy subjects received antipyrine (p
The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.